|
|
|
|
International Clinical Trials |
| |
| International Clinical Trials (ICT) is a specialist journal designed to provide global coverage of
key topics pertinent to the clinical trials sector.
Published quarterly, the journal offers a platform of
communication and information-sharing for executive and strategic decision makers, seeking
out new trends and marketing opportunities, as well as putting a spotlight on the latest innovations coming to market. ICT is specifically designed to be of interest to those actively seeking to source services for improved efficiency in what is an increasingly competitive market.
Prompted by the synergies between trial operations and wider contract research and outsourcing
issues, ICT joined forces with sister title European Pharmaceutical Contractor (EPC) in late-2015,
in a move that brings added value to both brands. With EPC now an inserted edition within ICT,
industry practitioners across these complementary subject areas now
have unrivalled access
to a wealth of shared views and analyses.
Connect with us on Twitter: follow @IntClinTrials
|
|
|
|
 |
|
|
 |
News and Press Releases |
 |
Worldwide Clinical Trials Expands Site Alliance Collaboration to Support Oncology Trials
18 May 2023 – RESEARCH TRIANGLE PARK, N.C. – (BUSINESS WIRE) – In
response to the growing and ever-changing clinical research landscape
and the need to bring innovative treatments to patients faster,
Worldwide Clinical Trials (Worldwide), a leading global, full-service
contract research organization (CRO), has expanded its Site Alliance
Collaboration with new partners across the United States and Europe.
Additions include new relationships with NEXT Oncology in Spain and the
pan-European Pratia Research Platform, along with its oncology research
units – supported by a dedicated Global Site Alliances role, established
at Worldwide last year.
More info >> |
|
 |
White Papers |
 |
|
The EC Definition of a Nanomaterial - Potential Measurement Methodologies
NanoSight
In October 2011 the European Commission
published a definition of Nanomaterials. This move followed more than six
years of scientific consideration of the potential toxicological and
environmental challenges posed by engineered nanomaterials.
More info >> |
|
|
